Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Avanir Pharmaceuticals, Inc. (AVNR)

-NasdaqGS
3.46 Up 0.04(1.17%) 4:00PM EDT
|After Hours : 3.46 0.00 (0.00%) 4:29PM EDT
Get the big picture on all your investments.
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Sep 30, 2013Jun 30, 2013Mar 31, 2013
Total Revenue 26,746   21,653   19,759   17,434  
Cost of Revenue1,292  1,222  1,078  1,003  
Gross Profit 25,454   20,431   18,681   16,432  
Operating Expenses
Research Development9,525  27,930  6,054  8,874  
Selling General and Administrative25,925  26,998  23,037  23,040  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (9,997) (34,498) (10,410) (15,483)
Income from Continuing Operations
Total Other Income/Expenses Net5  7  10  15  
Earnings Before Interest And Taxes(9,992)(34,490)(10,400)(15,467)
Interest Expense955  955  1,024  1,059  
Income Before Tax(10,947)(35,445)(11,425)(16,527)
Income Tax Expense -  3   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(10,947)(35,448)(11,425)(16,527)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (10,947) (35,448) (11,425) (16,527)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (10,947) (35,448) (11,425) (16,527)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.